Haemonetics Corporation, a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, announced an agreement with Epic, a...
ProSomnus Sleep Technologies ("ProSomnus"), the leader in patient-preferred medical devices for the treatment of Obstructive Sleep Apnea (OSA), announced the execution of definitive agreements...
The U.S. Food and Drug Administration announced the removal of N95 respirators from the agency's medical device shortage list, signaling that demand or projected...
Amgen presented new compelling data from the Phase 3 FOURIER open label extension (OLE) studies of Repatha (evolocumab) in adults with atherosclerotic cardiovascular disease...
